Posted by Michael Wonder on 13 Nov 2021
Highlights from CHMP 8-11 November 2021 meeting
12 November 2021 - EMA’s CHMP recommended eleven medicines for approval at its November 2021 meeting.
Regkirona (regdanvimab) and Ronapreve (casirivimab with imdevimab) are the first monoclonal antibodies to receive a positive opinion by the Committee for the treatment of COVID-19.
